Showing results (151-160 of 177) with videos related to

Sort By:
Pageof 18
The Oncologist|July 3, 2026
The Impact of Relative Dose Intensity on pCR in Neoadjuvant Chemotherapy of Muscle-Invasive Urothelial Cancer: a Multicentre Retrospective StudyGiuseppe Neola, Fabiano Flauto, Carmine Caso, et al.
Cancer Research|March 3, 2017
Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast CancerValerie M Jansen, Neil E Bhola, Joshua A Bauer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2023
CCNE1 and PLK1 Mediate Resistance to Palbociclib in HR+/HER2- Metastatic Breast CancerÁngel Guerrero-Zotano, Stefania Belli, Christoph Zielinski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2017
Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER+ Breast CancerLuigi Formisano, Kimberly M Stauffer, Christian D Young, et al.
Cancer Cell|January 25, 2020
Hyperactivation of TORC1 Drives Resistance to the Pan-HER Tyrosine Kinase Inhibitor Neratinib in HER2-Mutant CancersDhivya R Sudhan, Angel Guerrero-Zotano, Helen Won, et al.
Targeted Oncology|August 6, 2024
Pembrolizumab in Patients with Advanced Urothelial Carcinoma with ECOG Performance Status 2: A Real-World Study from the ARON-2 ProjectAlessandro Rizzo, Fernando Sabino Marques Monteiro, Yüksel Ürün, et al.
Frontiers in Immunology|May 4, 2026
Clinical activity and safety of nivolumab in combination with ipilimumab in metastatic melanoma: findings from REALIPINIVO, a real-world studyFrancesco Caraglia, Giuseppe Argenziano, Marcella Scala, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2018
ER+ Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 InhibitorsAngel L Guerrero-Zotano, Thomas P Stricker, Luigi Formisano, et al.
International Journal of Molecular Sciences|August 12, 2022
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, ItalyPasquale Pisapia, Antonino Iaccarino, Caterina De Luca, et al.
Cancers|August 14, 2025
Apalutamide Monotherapy in Metastatic Hormone-Sensitive Prostate Cancer: A Viable Alternative to First-Generation Anti-Androgen Agents to Avoid the Flare Phenomenon and an Effective Treatment for Achieving Early PSA ResponseGaetano Facchini, Andrea D'Arienzo, Antonella Nicastro, et al.
Pageof 18